BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12622417)

  • 1. NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer.
    Algül H; Adler G; Schmid RM
    Int J Gastrointest Cancer; 2002; 31(1-3):71-8. PubMed ID: 12622417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
    Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
    Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
    Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
    Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
    Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
    Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
    Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE
    Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of NF-kappa B in human bladder cancer and its clinical significance].
    Xie DH; Tang XD; Xia SJ; Tan JM; Wang XH; Cai Y
    Ai Zheng; 2002 Jun; 21(6):663-7. PubMed ID: 12452071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
    Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant rel/nfkb genes and activity in human cancer.
    Rayet B; Gélinas C
    Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
    Burgos P; Metz C; Bull P; Pincheira R; Massardo L; Errázuriz C; Bono MR; Jacobelli S; González A
    J Rheumatol; 2000 Jan; 27(1):116-27. PubMed ID: 10648027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
    J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the NF-kappa B and PI 3-kinase/Akt survival pathways in nerve growth factor-dependent neurons.
    Sarmiere PD; Freeman RS
    Mol Cell Neurosci; 2001 Sep; 18(3):320-31. PubMed ID: 11591132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells.
    Srivastava SK; Singh SV
    Carcinogenesis; 2004 Sep; 25(9):1701-9. PubMed ID: 15117814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-dependent activation of NF-kappaB: K63-linked ubiquitin chains: a link to cancer?
    Chen ZJ; Fuchs SY
    Cancer Biol Ther; 2004 Mar; 3(3):286-8. PubMed ID: 15004521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
    Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
    Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Rel/NF-kappa B transcription factors in senescence.
    Gosselin K; Abbadie C
    Exp Gerontol; 2003; 38(11-12):1271-83. PubMed ID: 14698807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2.
    Fahy BN; Schlieman M; Virudachalam S; Bold RJ
    Br J Cancer; 2003 Jul; 89(2):391-7. PubMed ID: 12865934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.
    Turco MC; Romano MF; Petrella A; Bisogni R; Tassone P; Venuta S
    Leukemia; 2004 Jan; 18(1):11-7. PubMed ID: 14574329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.
    van Hogerlinden M; Rozell BL; Ahrlund-Richter L; Toftgård R
    Cancer Res; 1999 Jul; 59(14):3299-303. PubMed ID: 10416581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain.
    Fognani C; Rondi R; Romano A; Blasi F
    Oncogene; 2000 Apr; 19(18):2224-32. PubMed ID: 10822372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.